Stadlauer Malzfabrik AG/ AT0000797303 /
09/05/2024 13:35:17 | Diferencia - | Volumen | Bid12:30:00 | Ask12:30:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.50EUR | - | 35 Volumen de negocios: 1,837.50 |
56.00Volumen de oferta: 100 | 58.00Tamaño/ Volumen/ Formato de Ask: 20 | 29.4 millonesEUR | 1.90% | 23.09 |
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
13:00
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
13:00
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
13:00
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
13:00
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
13:00
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
13:00
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spec...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página